Detalhe da pesquisa
1.
Advanced prescription of injectable anticancer drugs: Safety assessment in a European Comprehensive Cancer Centre using the risk matrix approach.
Br J Clin Pharmacol
; 90(5): 1333-1343, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38403473
2.
Exploring the added value of pretherapeutic MR descriptors in predicting breast cancer pathologic complete response to neoadjuvant chemotherapy.
Eur Radiol
; 33(11): 8142-8154, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37318605
3.
COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area.
Breast Cancer Res
; 22(1): 55, 2020 05 28.
Artigo
Inglês
| MEDLINE | ID: mdl-32460829
4.
The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort.
J Transl Med
; 17(1): 357, 2019 11 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31684954
5.
Critical role of sorafenib exposure over time for its antitumor activity in thyroid cancer.
Invest New Drugs
; 32(3): 569-72, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24399106
6.
Improving olaparib exposure to optimize adverse effects management.
Ther Adv Med Oncol
; 16: 17588359241248328, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38665845
7.
[Homologous recombination deficiency and PARP inhibitors in therapeutics]. / Défauts de la recombinaison homologue et inhibiteurs de PARP en thérapeutique.
Bull Cancer
; 109(1): 76-82, 2022 Jan.
Artigo
Francês
| MEDLINE | ID: mdl-34799081
8.
Oral Etoposide and Trastuzumab Use for HER2-Positive Metastatic Breast Cancer: A Retrospective Study from the Institut Curie Hospitals.
Cancers (Basel)
; 14(9)2022 Apr 24.
Artigo
Inglês
| MEDLINE | ID: mdl-35565244
9.
Sorafenib for patients with differentiated thyroid cancer.
Lancet
; 385(9964): 227-8, 2015 Jan 17.
Artigo
Inglês
| MEDLINE | ID: mdl-25706704
10.
Colony-stimulating factors for febrile neutropenia.
N Engl J Med
; 369(3): 285-6, 2013 07 18.
Artigo
Inglês
| MEDLINE | ID: mdl-23863066
11.
Adverse events of targeted therapies approved for women's cancers.
Int J Womens Dermatol
; 7(5Part A): 552-559, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-35024412
12.
Prevalence of drug-drug interactions in sarcoma patients: key role of the pharmacist integration for toxicity risk management.
Cancer Chemother Pharmacol
; 88(4): 741-751, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34304283
13.
Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients.
JNCI Cancer Spectr
; 5(1): pkaa090, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-33604509
14.
Advances in theranostic biomarkers for tumor immunotherapy.
Curr Opin Chem Biol
; 56: 79-90, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32217357
15.
The impact of body composition parameters on severe toxicity of nivolumab.
Eur J Cancer
; 124: 170-177, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31794927
16.
Clinical Pharmacokinetics and Pharmacodynamics of Dabrafenib.
Clin Pharmacokinet
; 58(4): 451-467, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30094711
17.
Differential Kinase Activation in Peripheral Blood Mononuclear Cells from Non-Small-Cell Lung Cancer Patients Treated with Nivolumab.
Cancers (Basel)
; 11(6)2019 May 31.
Artigo
Inglês
| MEDLINE | ID: mdl-31159331
18.
Is there an Exposure-Response Relationship for Nivolumab in Real-World NSCLC Patients?
Cancers (Basel)
; 11(11)2019 Nov 13.
Artigo
Inglês
| MEDLINE | ID: mdl-31766292
19.
[Adjuvant olaparib - High risk early breast cancer with BRCA1 or BRCA2 germline mutation]. / Olaparib en adjuvant Cancers du sein précoces à haut risque avec mutation germinale BRCA1/2.
Bull Cancer
; 110(11): 1092-1093, 2023 11.
Artigo
Francês
| MEDLINE | ID: mdl-37716861
20.
Clinical Potential of HER2 PET as a Predictive Biomarker to Guide the Use of Trastuzumab Deruxtecan in Breast Cancer Patients.
J Nucl Med
; 64(7): 1164-1165, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37230529